Understanding and addressing lung cancer risks in Native Hawaiians.
Official title: Project 2: Mitigating Lung Cancer Disparities in Native Hawaiians: A Population-Based Approach to Evaluate Prevention Barriers and Lung Tumor Biology
Funded at University of Hawaii at Manoa · NIH-10931598 · Data updated 2026-11-12
This study is looking at why Native Hawaiians have a higher risk of lung cancer and worse survival rates compared to others, and it aims to find ways to improve early detection and prevention, especially through low-dose CT scans, by understanding the unique challenges this community faces.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Hawaii at Manoa NIH-funded |
| Lab location | 1 site (Honolulu, United States) |
| Project start | September 19, 2023 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $264,405 |
| NIH project number | 5P20CA275734-02 |
| Project ID | NIH-10931598 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include Native Hawaiians aged 50 to 80 years with a history of smoking or those who have quit within the past 15 years.
✕Less likely to help
Patients who do not identify as Native Hawaiians or do not meet the age and smoking history criteria may not benefit from this research.
What this research studies
This research investigates the higher risk and poorer survival rates of lung cancer among Native Hawaiians compared to other populations. It focuses on identifying barriers to lung cancer prevention and screening, particularly the use of low-dose Computed Tomography (LDCT) for early detection. The study will analyze genetic, epigenetic, and behavioral factors that contribute to these disparities, aiming to improve lung cancer outcomes in this community. By engaging with the local population, the research seeks to develop tailored interventions that address specific needs and challenges.
Why it matters
Potential benefit: If successful, this research could lead to improved lung cancer prevention and early detection strategies for Native Hawaiians, ultimately enhancing survival rates.
How similar studies have gone: Previous research has successfully identified disparities in lung cancer risk among different populations, suggesting that targeted approaches can lead to meaningful improvements in health outcomes.
Where this research is happening
-
University of Hawaii at Manoa
Honolulu, United States Active
Researchers
- Principal investigator: Park, Sungshim Lani — University of Hawaii at Manoa
- Study coordinator: Park, Sungshim Lani
Related research
Other NIH-funded projects on the same topics.
-
Blood-based markers to identify lung cancer risk in never-smokers
A researchers team at NYU School of Medicine is testing blood tests that might flag higher lung cancer risk in people who have never smoked, helping decide who might need screening.
-
Integrative Analysis of Lung Cancer Risk and Its Causes
A large, multi-part study at the University of New Mexico is exploring why lung cancer happens and how to better prevent and detect it.
-
Integrative Analysis of Lung Cancer Risk and Causes
A large NIH project is exploring how tobacco use, behavior, biology, and screening practices influence lung cancer risk and outcomes to help prevent and detect it earlier.
-
Digital health strategies to expand lung cancer screening in safety-net clinics
A funded project aims to help low-resource clinics increase the use of lung cancer screening for patients who smoke or are at risk.
-
Proteomics-guided matching of lung cancer tumors to preclinical models
This grant aims to improve how we match a patient’s lung cancer tumor to the right preclinical models using protein data.
-
Optimizing lung cancer care with smart tools for prevention, early detection, treatment, and survivorship
A U01 grant using AI and biomarkers to improve lung cancer prevention, screening, treatment, and survivorship care for people at risk or living with lung cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.